You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Bulk Pharmaceutical API Sources for QUTENZA


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for QUTENZA

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free M2028_SIGMA ⤷  Get Started Free
Calbiochem ⤷  Get Started Free 211274 ⤷  Get Started Free
R&D Chemicals ⤷  Get Started Free 8986 ⤷  Get Started Free
Biosynth ⤷  Get Started Free C-1700 ⤷  Get Started Free
Hangzhou Trylead Chemical Technology ⤷  Get Started Free TL8002946 ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 1548943 ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 21750_SIGMA ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for QUTENZA

Last updated: July 28, 2025

Introduction

QUTENZA (capsaicin) is a topical medication used for the management of neuropathic pain associated with postherpetic neuralgia (PHN). The active pharmaceutical ingredient (API) in QUTENZA is capsaicin, a compound derived from chili peppers (Capsicum annuum), which acts as a transient receptor potential vanilloid 1 (TRPV1) receptor agonist. The manufacturing process of QUTENZA necessitates high-quality, pharmaceutical-grade capsaicin APIs from reputable global sources. Ensuring the procurement of compliant APIs is critical for product safety, efficacy, regulatory compliance, and supply chain reliability.

This report examines major sources of bulk API suppliers for capsaicin employed in QUTENZA, analyzing their manufacturing capabilities, regulatory status, quality standards, and strategic positioning in the pharmaceutical supply chain.


Regulatory Standards and Quality Requirements

APIs intended for dermatological use in QUTENZA must adhere to stringent quality specifications, including:

  • GMP compliance: Good Manufacturing Practices adherence to ensure purity, potency, and consistent quality.
  • Pharmacopoeial standards: API must meet or exceed standards specified by pharmacopeias such as USP, EP, or JP.
  • Purity and impurity profile: High purity (>99%) with minimal residual solvents and microbial contaminants.
  • Regulatory acceptance: Ability to supply APIs authorized for use in major markets (FDA, EMA, PMDA).

Historical supply and availability of capsaicin APIs vary by source, determined by geographic, regulatory, and technological factors.


Major API Suppliers for Capsaicin

1. Meryx Inc.

Overview: Meryx Inc., based in the United States, is a notable supplier specializing in plant-derived APIs, including capsaicin. The company emphasizes natural extraction methods aligned with pharmaceutical standards.

Capabilities:

  • High-purity capsaicin extracted from chili peppers.
  • Adheres to GMP standards, suitable for pharmaceutical applications.
  • Offers custom synthesis, characterization, and supply chain services.

Regulatory Status:

  • Products meet USP and other pharmacopoeial standards.
  • Actively supplies to pharmaceutical formulators and research institutions globally.

Strengths & Strategy:

  • Expertise in natural product extraction and purification.
  • Established GMP certification, aligned with U.S. regulatory expectations.
  • Focus on sustainable sourcing and traceability.

2. Indofine Chemical Company

Overview: An industry leader in specialty chemicals and APIs, Indofine supplies pharmaceutical-grade capsaicin globally. The company combines extensive chemical manufacturing expertise with strict quality management.

Capabilities:

  • Plusieurs grades of capsaicin, including pharmaceutical-grade.
  • Process development for large-scale extraction and synthesis.
  • Compliance with GMP, ISO certifications.

Regulatory Status:

  • Certified for pharmaceutical use with documentation aligned to regulatory standards.
  • Supplies to major pharma companies and CROs.

Strengths & Strategy:

  • Long-standing reputation with extensive chemical manufacturing facilities.
  • Capable of delivering bulk quantities in compliance with regulatory standards.
  • Robust quality assurance programs.

3. Phytochemical and Botanical Suppliers (e.g., Phytotech Labs, Indfrag)

Overview: These suppliers specialize in botanical extracts, including capsaicin, offering both natural extracts and pure API forms.

Capabilities:

  • Extraction from chili peppers with controlled processes.
  • High purity (≥99%) and consistent batch-to-batch quality.
  • Supply larger bulk quantities suitable for API manufacturing.

Regulatory Status:

  • Many suppliers possess GMP certification.
  • APIs often meet USP/NF standards.

Strengths & Strategy:

  • Emphasis on natural, plant-derived API sustainability.
  • Competitive pricing and flexible supply options.

4. Chinese and Indian API Manufacturers

Overview: Emerging and established pharmaceutical manufacturers from China and India produce capsaicin APIs meeting global quality standards.

Examples:

  • Zhejiang Xinhua Pharmaceutical Co. (China)
  • Wockhardt Ltd. (India)
  • Sun Pharmaceutical Industries Ltd. (India)

Capabilities:

  • Large-scale production with GMP certification.
  • Cost-effective manufacturing with high throughput.

Regulatory Status:

  • APIs often approved or accepted in international markets, subject to validation.
  • Challenges may include variability in documentation and regulatory harmonization.

Strengths & Strategy:

  • Cost competitiveness.
  • Expansion into international markets through regulatory approvals.

Key Factors Influencing API Sourcing Decisions

Quality Assurance

Ensuring APIs meet pharmacopeial standards is paramount. Suppliers with proven GMP certification and regulatory acceptance reduce risk.

Supply Chain Security

Long-term partnerships with reliable manufacturers mitigate shortages and facilitate regulatory compliance.

Regulatory Navigation

Suppliers with experience in global regulatory processes (FDA, EMA, PMDA) enable smoother market entry and compliance.

Cost Considerations

Balancing quality with cost-effectiveness is critical, especially given the high purity requirements for QUTENZA.

Sustainability and Traceability

Growing emphasis on sustainable sourcing and traceability aligns with corporate responsibility standards.


Emerging Trends and Future Outlook

The API landscape for capsaicin reflects broader trends in natural product sourcing and pharmaceutical manufacturing:

  • Increasing demand for natural, plant-derived APIs with high purity.
  • Expansion of Chinese and Indian manufacturing capacities meeting international standards.
  • Growing prominence of vertically integrated suppliers offering both extraction and synthesis.
  • Advances in green extraction and purification technologies reducing environmental impact.

Overall, the sourcing of capsaicin API for QUTENZA remains competitive, with key suppliers maintaining high standards to meet regulatory and market demands.


Key Takeaways

  • Quality and compliance are non-negotiable; suppliers with GMP certification and USP/NF standards are preferred.
  • Major sources include Meryx Inc., Indofine, specialized botanical extract companies, and Indian/Chinese manufacturers.
  • Supply chain reliability and sustainability are critical for uninterrupted production.
  • Cost and regulatory alignment influence supplier selection; emerging markets offer competitive advantages but require rigorous validation.
  • Technological advances enable high purity extraction and synthesis, broadening supplier options while maintaining stringent quality standards.

Frequently Asked Questions

1. What criteria are essential when selecting a bulk API supplier for capsaicin?

Suppliers should demonstrate GMP compliance, USP or pharmacopoeial standard adherence, consistent high purity (>99%), proven regulatory track record, and ability to supply large, validated batches reliably.

2. Are natural extraction methods preferable for capsaicin API production?

Natural extraction from chili peppers preserves botanical integrity and consumer perception but requires rigorous purification to meet pharmaceutical standards. Synthesis may offer more consistency but can be costlier.

3. Do Chinese and Indian API manufacturers meet global regulatory standards?

Many Chinese and Indian API manufacturers have achieved GMP certification and obtained approvals in various markets, but due diligence is required to verify compliance and documentation standards.

4. How does the rising demand for natural APIs influence supply chains?

It prompts suppliers to invest in sustainable sourcing and green extraction technologies, increasing availability but also emphasizing the need for traceability and quality assurance.

5. What are the main challenges in API sourcing for topical medications like QUTENZA?

Ensuring high purity, batch consistency, regulatory compliance, sustainable sourcing, and supply chain stability pose ongoing challenges for formulators and procurement teams.


Sources:

[1] United States Pharmacopeia. USP Monographs for Capsaicin. 2020.
[2] European Pharmacopoeia. Capsaicin Specification. 2022.
[3] Meryx Inc. Product datasheets and GMP compliance certifications.
[4] Indofine Chemical Company. API manufacturing capabilities.
[5] Industry reports on natural product APIs and global supply chain trends, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.